Erenzo 50 mg (Tablet)

Unit Price: ৳ 350.00 (1 x 10: ৳ 3,500.00)
Strip Price: ৳ 3,500.00

Medicine Details

Indications

  • Treatment of symptomatic anemia associated with chronic kidney disease (CKD) in adult patients

Description

  • First-in-class orally administered HIF-PH inhibitor
  • Promotes erythropoiesis through increasing endogenous production of erythropoietin
  • Improves iron regulation
  • Overcomes EPO-suppressive effects of inflammation on hemoglobin synthesis and red blood cell production by downregulating hepcidin

Pharmacology

  • Orally bioavailable
  • Hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI)
  • Binds to and inhibits HIF-PH
  • Increases endogenous erythropoietin production
  • Reduces expression of hepcidin
  • Improves iron availability
  • Boosts hemoglobin (Hb) levels
  • Regulates genes required for erythropoiesis and iron metabolism

Dosage & Administration

  • Oral administration
  • Taken three times per week
  • Individualized dose to achieve and maintain target Hb levels of 10 to 12 g/dL
  • Dosing based on erythropoiesis-stimulating agent treatment
  • Dose adjustments based on Hb monitoring
  • Missed dose instructions
  • Can be taken with or without food

Interaction

  • Drug-drug interactions with phosphate binders, gemfibrozil, probenecid, OATP1B1, BCRP substrates
  • Specific risks and recommendations for each interaction

Side Effects

  • Common adverse reactions: hypertension, vascular access thrombosis, diarrhea, peripheral edema, hyperkalemia, nausea

Pregnancy & Lactation

  • Contraindicated during pregnancy or breastfeeding

Precautions & Warnings

  • Initiation caution
  • Potential to initiate thrombotic vascular events (TVEs)
  • Caution in patients with history of seizures
  • Avoid use in serious signs and symptoms of infection or liver disorder
  • Not to be initiated in pregnant women

Use in Special Populations

  • Not indicated for use in children
  • Not recommended for patients with severe hepatic impairment

Overdose Effects

  • Symptoms of overdose
  • Treatment measures for overdose
  • Not removed by dialysis

Therapeutic Class

  • Drugs for Haemolytic Hypoplastic & Renal Anemia

Storage Conditions

  • Store in a cool, dry place below 30°C
  • Keep away from light and moisture
  • Keep out of reach of children

Related Brands